|
Video: What is a Stock Split?
|
|
PolyPid is a clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using its proprietary Polymer-Lipid Encapsulation matrix (PLEX) technology. Co.'s product candidates are designed to address diseases with unmet medical needs by pairing its PLEX technology with drugs already approved by the U.S. Food and Drug Administration. Co.'s PLEX technology is designed to deliver drugs directly to precise sites in the body at predetermined release rates and over durations ranging from several days to several months. Co.'s primary product candidate, D-PLEX100, is for abdominal (soft) tissue. According to our PolyPid stock split history records, PolyPid has had 1 split. | |
|
PolyPid (PYPD) has 1 split in our PolyPid stock split history database. The split for PYPD took place on September 21, 2023. This was a 1 for 30 reverse split, meaning for each 30 shares of PYPD owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 33.3333333333333 share position following the split.
When a company such as PolyPid conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the PolyPid stock split history from start to finish, an original position size of 1000 shares would have turned into 33.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PolyPid shares, starting with a $10,000 purchase of PYPD, presented on a split-history-adjusted basis factoring in the complete PolyPid stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/29/2020 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$569.70 |
|
End price/share: |
$4.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.20% |
|
Average Annual Total Return: |
-71.73% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$79.99 |
|
Years: |
3.82 |
|
|
|
Date |
Ratio |
09/21/2023 | 1 for 30 |
|
|